Health Care & Life Sciences » Pharmaceuticals | Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW616
Market Cap
KRW193.79 B
Shares Outstanding
14.35 M
Public Float
8.29 M

Profile

Address
66 Jeyakgongdan 1-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.dhnp.co.kr
Updated 09/14/2018
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. It operates through the pharmaceutical and animal health product business divisions. The pharmaceutical division provides analgesics anti-inflammatory drugs and antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics and immunosuppressants, cardiovascular drugs, gatrointestinal drugs, muscle relaxants, antispasmodics, cream or ointments and others.

Financials

View All

Wan-Jin Lee
Chairman
Gun-Woo Bae
Co-President & Director